Supplements challenger Heights valued at £60m in latest funding round

Heights supplements

The latest round values the company at £57.8m, a significant jump from the £33m level hit during the previous £2m fundraising in 2024

Supplements challenger Heights has raised a further £2m to support its rapid growth and boost stock inventory as the business pushes to keep up with consumer demand.

Already have an account? Sign in here

Want access to this article?

Register for LIMITED access

REGISTER FOR FREE

Get PREMIUM access for £1 a week

SUBSCRIBE NOW